Mitogen-activated protein kinase 1 regulates platelet function and thrombus formation

Area of Science:

• Hematology
• Molecular Biology
• Cardiovascular Research

Background:

• Mitogen-activated protein kinase 1 (MAPK1), also known as ERK2, is a Ser/Thr kinase.
• Pharmacologic inhibition of MAPK1 has shown varied effects on platelet function due to off-target effects.
• The specific role of MAPK1 in platelet activity and thrombus formation remains largely unknown.

Purpose of the Study:

• To elucidate the role of MAPK1 in regulating platelet activity.
• To investigate the impact of MAPK1 on thrombus formation in vivo.
• To identify the molecular mechanisms underlying MAPK1-mediated platelet function.

Main Methods:

• Generation of megakaryocyte/platelet-specific MAPK1 knockout mice.
• Assessment of platelet aggregation, activation, procoagulant activity, spreading, and clot retraction.
• Evaluation of in vivo hemostatic function using tail bleeding time and arterial/venous thrombosis models.

Main Results:

• MAPK1 deficiency significantly impaired arterial and venous hemostasis and thrombosis.
• MAPK1-deficient platelets exhibited reduced aggregation, granule release, αIIbβ3 activation, calcium mobilization, and procoagulant activity.
• MAPK1 interacts with talin1, phosphorylates it at Ser425, and this interaction is critical for platelet function and β3 phosphorylation.

Conclusions:

• MAPK1 plays a critical role in regulating platelet function and thrombus formation.
• A novel mechanism involving MAPK1-talin1 interaction in platelet activation was identified.
• MAPK1 represents a potential therapeutic target for managing thrombotic disorders.